乐观
$8.60
情景价格
$12.350
-0.378 (-3.06%)收盘时
American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.
American Well Corp is currently a hold. The stock is priced at $12.52, which is below the average analyst price target of $12, indicating limited upside potential in the near term. The RSI is at 37.8, suggesting the stock is nearing oversold territory, but the recent 5-day change of -7.53% indicates downward momentum. The company has shown improvement with a narrowed net loss of $9.6 million in Q2 2026, but risks remain due to ongoing losses and competitive pressures in the telehealth market.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Amwell Receives 2026 Technology Innovation Leadership Award

Amwell Grants RSUs to New Employees as Inducement

Amwell Grants RSUs to New Employees as Inducement

Biotech Companies See Significant Stock Gains

American Well Q2 2026 Earnings Call Highlights
American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).
American Well Corp is currently a hold. The stock is priced at $12.52, which is below the average analyst price target of $12, indicating limited upside potential in the near term. The RSI is at 37.8, suggesting the stock is nearing oversold territory, but the recent 5-day change of -7.53% indicates downward momentum. The company has shown improvement with a narrowed net loss of $9.6 million in Q2 2026, but risks remain due to ongoing losses and competitive pressures in the telehealth market.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。